Market
Synopsis of Global Anti-Viral Drugs Market:
Market
Scenario:
Viruses
are the ultimate parasites as they derive nutrition from the host cell and also
hijack and direct its metabolic machinery to synthesize new virus particles.
Viruses can live and replicate only inside host body. Anti-viral drugs are
specifically used to treat viral infections and act mostly by inhibiting their
target viruses. The growth of antiviral drugs market is driven by factors such
as rise in healthcare expenditure, growing research and development investment,
emergence of virus life-threatening diseases like bird flu, strong development
pipeline and increasing incidence rates of viral infections particularly HIV.
WHO estimates 36.7 million people are suffering from HIV/AIDS worldwide with
1.1 million deaths of AIDS-related illnesses in 2015.
Taking all these factors the market for anti-viral
drugs is expected to reach $62.67 billion by the end of the forecast period
growing at a CAGR of 6.9%.
Key
Players for Global Anti-Viral Drugs Market:
Some of the key players in this market are: Johnson & Johnson, Merck & Co. Inc., Gilead Sciences Inc., Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Abbott Laboratories, Novartis International AG, Astra Zeneca AB, Cipla Inc.
Some of the key players in this market are: Johnson & Johnson, Merck & Co. Inc., Gilead Sciences Inc., Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Abbott Laboratories, Novartis International AG, Astra Zeneca AB, Cipla Inc.
Market
Segments:
Global Anti-viral drugs market has been segmented on the basis of application, which comprises hepatitis, HIV/AIDS, herpes, influenza and others. On the basis of mechanism of action; market is segmented into nucleotide polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors and others.
Global Anti-viral drugs market has been segmented on the basis of application, which comprises hepatitis, HIV/AIDS, herpes, influenza and others. On the basis of mechanism of action; market is segmented into nucleotide polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors and others.
Intended Audience
- Anti-viral
drugs Manufacturers
- Anti-viral
drugs Suppliers
- Private
Research Laboratories
- Research
and Development (R&D) Companies
- Market
Research and Consulting Service Providers
- Government
Research Laboratories
- Contract
Manufacturing Organizations
Regional
Analysis of Global Anti-Viral Drugs Market:
Globally
America is the largest market for anti-viral drugs. North America dominated the
market for anti-viral drugs with a share of greater than 30%. Europe is
the second-largest market for anti-viral drugs. Asia pacific region is expected
to be fastest growing region in anti-viral drugs market.
Browse
Complete 84 Pages Premium Research Report Enabled with Respective Tables and
Figures at @ https://www.marketresearchfuture.com/reports/anti-viral-drugs-market-2454
Table Of Contents
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s Five Forces Model
4.1.1 Bargaining Power Of Suppliers
4.1.2 Bargaining Power Of Customer
4.1.3 Intensity Of Competitor’s
4.1.4 Threat Of New Entrants
...Continued
About US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment